Trial
NCT00869856
Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
Phase IIIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Sandoz
Collaborators
—
Condition
Anemia
Intervention
HX575 solution for s.c. administration
Why stopped
investigation of adverse events in a related clinical study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-02